Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 7Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 670Carcinoma, Non-Small-Cell Lung 460Prostatic Neoplasms 387Neoplasms 383Lung Neoplasms 264Multiple Myeloma 249Colorectal Neoplasms 234Neoplasm Metastasis 214Melanoma 203Ovarian Neoplasms 166Leukemia, Myeloid, Acute 165Pancreatic Neoplasms 155Carcinoma, Renal Cell 142Squamous Cell Carcinoma of Head and Neck 141Lymphoma 137Brain Neoplasms 133Leukemia, Lymphocytic, Chronic, B-Cell 126Glioblastoma 126Recurrence 125Lymphoma, Non-Hodgkin 124Carcinoma, Hepatocellular 119Head and Neck Neoplasms 114Urinary Bladder Neoplasms 111Triple Negative Breast Neoplasms 110Stomach Neoplasms 108Precursor Cell Lymphoblastic Leukemia-Lymphoma 105Uterine Cervical Neoplasms 102Hematologic Neoplasms 99Lymphoma, Follicular 96Sarcoma 94

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Solid Tumors, Adult × 1 year × Clear all
NCT05354323 2025-06-26

NECVAX-NEO1 in Addition to Checkpoint Inhibitor in Patients With Solid Tumors

NEC OncoImmunity AS

Phase 1 Active not recruiting
6 enrolled
Other solid neoplasm

Solid Tumors, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡